TCS named 'leader in drug safety services'
India | News | By BioSpectrum Bureau | 0 Comment | 01 Mar, 2013
Bangalore: India-based Tata Consultancy Services has been designated as a Leader in Life Science Drug Safety Services (...Read more
BSA-CMR Survey: Oncology is the top therapeutic focus area for CROs in APAC
India | Analysis | By BioSpectrum Bureau | 3 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
Aurobindo Pharma gets FDA approval for diabetes drug
India | News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2012
Bangalore: India-based Aurobindo Pharma has received tentative approval from the US Food & Drug Administration for p...Read more
India | Analysis | By BioSpectrum Bureau | 0 Comment | 28 Nov, 2012
The medical devices industry has progressed by leaps and bounds in the recent past and this is evident from the several ...Read more
NCBS prof wins Infosys prize in life science
India | News | By BioSpectrum Bureau | 0 Comment | 23 Nov, 2012
Bangalore: India-based Infosys Science Foundation has chosen Dr Satyajit Mayor, professor, cellular organization and sig...Read more
Aethlon Medical expands access to Hemopurifier therapy
India | News | By BioSpectrum Bureau | 0 Comment | 10 Aug, 2012
New Delhi: Aethlon Medical, a pioneer in developing selective therapeutic filtration devices to address infectious disea...Read more
10 point guide to BIRAC funding for businesses in India
India | News | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2012
With the manate to support and tend start-ups in the biotechnology sector and small and medium enterprises, the Biotech...Read more
Elder pharma announces future plans
India | News | By BioSpectrum Bureau | 0 Comment | 26 Dec, 2013
Singapore: With an aim to focus on its anti-infectives market, Elder Pharma has announced that it plans to strengthen in...Read more
India revokes Roche's cancer drug Herceptin patent
India | News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2013
New Delhi: In what is being criticized as yet another miserable experience created by India's intellectual property and ...Read more
US FDA clears GVK Bio's Ahmedabad facility
India | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2012
Hyderabad: The Ahmedabad Clinical Pharmacology Unit of GVK Biosciences, Asia's leading contract research organization, h...Read more
BIORx to hold India's first bio-acceleration program
India | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2013
New Delhi: BIORx Venture Advisors (BIORx) is going to launch India's first dedicated bio-acceleration program with the t...Read more
BioEnable to prevent baby mix-ups in hospitals
India | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2013
Mumbai: BioEnable Technologies, a leading identification and tracking solutions company based in the city of Pune, India...Read more
Indian apex court raps govt over clinical trial data
India | Analysis | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2013
Giving a clear call for accountability, the Supreme Court of India, on January 3, 2013, sternly reprimanded the Ministry...Read more
Neuland revenue drops 2.5% to $19.56 mn
India | Company results | By BioSpectrum Bureau | 0 Comment | 14 Feb, 2013
Hyderabad: Neuland Laboratories, a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), comp...Read more
NIH cancels 40 ongoing clinical trials in India
India | Regulatory | By BioSpectrum Bureau | 4 Comment | 12 Jul, 2013
Singapore: In what is proving to be a major setback for the Indian clinical research industry, reports reveal that the w...Read more
Dr Rajput: Enjoy challenges to overcome them
India | Influencers | By BioSpectrum Bureau | 4 Comment | 18 Jan, 2013
Dr Anuradha Rajput, managing director, Icon Central Laboratories, India, has been working with the company since the pas...Read more
DCGI asks Wockhardt, Ranbaxy to explain lapses
India | Regulatory | By BioSpectrum Bureau | 4 Comment | 02 Sep, 2013
Singapore: The Indian Drug Controller General of India (DCGI) has written a letter to the drug maker Wockhardt to explai...Read more
A deal undone: Biocon, Pfizer go back on alliance
India | Analysis | By BioSpectrum Bureau | 0 Comment | 30 Apr, 2012
It was a path-breaking deal that had many eye balls rolling. Industry soothsayers predicted it to be the beginning of an...Read more